MP87-04 TIMING OF SALVAGE ANDROGEN DEPRIVATION THERAPY FOLLOWING PROSTATE RADIOTHERAPY DOES NOT ADVERSELY AFFECT ALL-CAUSE OR PROSTATE CANCER SPECIFIC SURVIVAL
Sagalovich D, Leapman M, Sfakianos J, Hall S, Stock R, Stone N. MP87-04 TIMING OF SALVAGE ANDROGEN DEPRIVATION THERAPY FOLLOWING PROSTATE RADIOTHERAPY DOES NOT ADVERSELY AFFECT ALL-CAUSE OR PROSTATE CANCER SPECIFIC SURVIVAL. Journal Of Urology 2015, 193: e1085. DOI: 10.1016/j.juro.2015.02.1949.Peer-Reviewed Original ResearchSalvage androgen deprivation therapyAndrogen deprivation therapyProstate Cancer SpecificDeprivation therapyCancer-SpecificProstate radiotherapyRadiotherapyTherapy